SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-17-000054
Filing Date
2017-05-22
Accepted
2017-05-22 08:23:47
Documents
5
Period of Report
2017-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kmay212017.htm 8-K 21571
2 EXHIBIT 99.1 athos3nejmpublicationpr0.htm EX-99.1 10357
3 athos3nejmpublicationpr0001.jpg GRAPHIC 217328
4 athos3nejmpublicationpr0002.jpg GRAPHIC 215143
5 athos3nejmpublicationpr0003.jpg GRAPHIC 153974
  Complete submission text file 0000920465-17-000054.txt   841254
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 17859728
SIC: 2836 Biological Products, (No Diagnostic Substances)